879093-02-4 Usage
Description
4-Chloro-2,5-difluorobenzaldehyde is an organic compound characterized by the presence of a chlorine atom at the 4th position and two fluorine atoms at the 2nd and 5th positions on a benzene ring. It features an aldehyde functional group, which makes it a versatile intermediate in organic synthesis.
Uses
Used in Pharmaceutical Industry:
4-Chloro-2,5-difluorobenzaldehyde is used as a reactant in the synthesis of quinuclidine amide compounds. These compounds are pharmaceutically acceptable salts that serve as alpha-7 nicotinic acetylcholine receptor agonists. They are valuable in the development of medications targeting cognitive functions and neurological disorders, such as Alzheimer's disease and schizophrenia, due to their potential to modulate neurotransmission and improve cognitive performance.
Check Digit Verification of cas no
The CAS Registry Mumber 879093-02-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,9,0,9 and 3 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 879093-02:
(8*8)+(7*7)+(6*9)+(5*0)+(4*9)+(3*3)+(2*0)+(1*2)=214
214 % 10 = 4
So 879093-02-4 is a valid CAS Registry Number.
InChI:InChI=1/C7H3ClF2O/c8-5-2-6(9)4(3-11)1-7(5)10/h1-3H
879093-02-4Relevant articles and documents
Therapeutic diphenyl ether ligands
-
Page/Page column 32, (2010/10/20)
This invention is directed to compounds of formula Ia, Ib or Ic and to pharmaceutical compositions thereof: or a prodrug thereof and a pharmaceutically acceptable carrier, wherein the R groups are defined in the specification; and, in which the dashed line represents an optional double bond. The invention is also directed to methods of treating, diagnosing, and preventing disorders of the central nervous system that are associated with 5HT receptors, including obesity, attention deficit disorder, migraine, depression, epilepsy, anxiety, Alzheimer's disease, withdrawal from drug abuse, pain, schizophrenia, stress-related disorders, panic disorder, sleep disorders, phobias, obsessive compulsive disorder, post-traumatic-stress syndrome, immune system depression, stress-induced gastrointestinal dysfunction, stress-induced cardiovascular dysfunction, and sexual dysfunction.
